isoproterenol has been researched along with ggti-2133 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clapp, KM; Ellsworth, ML; Sprague, RS; Stephenson, AH | 1 |
1 other study(ies) available for isoproterenol and ggti-2133
Article | Year |
---|---|
Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Adult; Alkyl and Aryl Transferases; Animals; Anticholesteremic Agents; Cholesterol; Erythrocyte Deformability; Erythrocytes; Female; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Isoproterenol; Leucine; Male; Middle Aged; Naphthalenes; Nitric Oxide Synthase Type III; Oxygen; Partial Pressure; Peptides; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Simvastatin; Wasp Venoms; Young Adult | 2013 |